Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration

Two distinct Thr phosphorylation events within the cytoplasmic domain of the NG2 proteoglycan help regulate the cellular balance between proliferation and motility. Protein kinase Cα mediates the phosphorylation of NG2 at Thr2256, resulting in enhanced cell motility. Extracellular signal–regulated kinase phosphorylates NG2 at Thr2314, stimulating cell proliferation. The effects of NG2 phosphorylation on proliferation and motility are dependent on β1-integrin activation. Differential cell surface localization of the two distinctly phosphorylated forms of NG2 may be the mechanism by which the NG2–β1-integrin interaction promotes proliferation in one case and motility in the other. NG2 phosphorylated at Thr2314 colocalizes with β1-integrin on microprotrusions from the apical cell surface. In contrast, NG2 phosphorylated at Thr2256 colocalizes with β1-integrin on lamellipodia at the leading edges of cells. Thus, phosphorylation and the resulting site of NG2–integrin localization may determine the specific downstream effects of integrin signaling.

[1]  C. Gladson,et al.  New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.

[2]  Peter Canoll,et al.  Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis , 2006, Glia.

[3]  Y. Wen,et al.  Molecular basis of interaction between NG2 proteoglycan and galectin‐3 , 2006, Journal of cellular biochemistry.

[4]  Paola Defilippi,et al.  p130Cas: a versatile scaffold in signaling networks. , 2006, Trends in cell biology.

[5]  A. Nishiyama,et al.  NG2 Glial Cells Provide a Favorable Substrate for Growing Axons , 2006, The Journal of Neuroscience.

[6]  J. Arthur,et al.  Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. , 2006, The Biochemical journal.

[7]  R. Ginnan,et al.  PKC-δ-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle , 2005 .

[8]  Jia-Ren Lin,et al.  Bidirectional signals transduced by DAPK–ERK interaction promote the apoptotic effect of DAPK , 2005, The EMBO journal.

[9]  T. Mustelin,et al.  Phosphorylation of NG2 Proteoglycan by Protein Kinase C-α Regulates Polarized Membrane Distribution and Cell Motility* , 2004, Journal of Biological Chemistry.

[10]  W. Stallcup,et al.  NG2 Proteoglycan Promotes Endothelial Cell Motility and Angiogenesis via Engagement of Galectin-3 and α3β1 Integrin , 2004 .

[11]  S. Ferrone,et al.  Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms , 2004, The Journal of cell biology.

[12]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[13]  C. Bole-Feysot,et al.  Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. , 2004, American journal of physiology. Cell physiology.

[14]  A. Musti,et al.  Differential Phosphorylation of c-Jun and JunD in Response to the Epidermal Growth Factor Is Determined by the Structure of MAPK Targeting Sequences* , 2004, Journal of Biological Chemistry.

[15]  James E. Goldman,et al.  Multiple Cell Populations in the Early Postnatal Subventricular Zone Take Distinct Migratory Pathways: A Dynamic Study of Glial and Neuronal Progenitor Migration , 2003, The Journal of Neuroscience.

[16]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Patrick Cottin,et al.  MAP Kinase-dependent Degradation of p27Kip1 by Calpains in Choroidal Melanoma Cells , 2003, The Journal of Biological Chemistry.

[18]  K. Nave,et al.  The Proteoglycan NG2 Is Complexed with α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by the PDZ Glutamate Receptor Interaction Protein (GRIP) in Glial Progenitor Cells , 2003, The Journal of Biological Chemistry.

[19]  Lewis C Cantley,et al.  Hitting the Target: Emerging Technologies in the Search for Kinase Substrates , 2002, Science's STKE.

[20]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[21]  W. Stallcup.  The NG2 proteoglycan: Past insights and future prospects , 2002, Journal of neurocytology.

[22]  M. Israel,et al.  Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. , 2002, Cancer research.

[23]  Olav Haraldseth,et al.  NG2 proteoglycan promotes angiogenesis‐dependent tumor growth in the central nervous system by sequestering angiostatin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  D. Salter,et al.  NG2/HMPG modulation of human articular chondrocyte adhesion to type VI collagen is lost in osteoarthritis , 2001, The Journal of pathology.

[25]  K Kornfeld,et al.  Docking Sites on Substrate Proteins Direct Extracellular Signal-regulated Kinase to Phosphorylate Specific Residues* , 2001, The Journal of Biological Chemistry.

[26]  W. Stallcup,et al.  Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization. , 2001, Journal of cell science.

[27]  R. Lefkowitz,et al.  New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades , 2001, Oncogene.

[28]  K. Nave,et al.  The AN2 Protein Is a Novel Marker for the Schwann Cell Lineage Expressed by Immature and Nonmyelinating Schwann Cells , 2001, The Journal of Neuroscience.

[29]  E. Ruoslahti,et al.  Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain* , 2000, The Journal of Biological Chemistry.

[30]  C. Lombardo,et al.  Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen)* , 2000, The Journal of Biological Chemistry.

[31]  E. Pasquale,et al.  The multi‐PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane‐spanning proteoglycan NG2 , 2000, Journal of cellular biochemistry.

[32]  Angus C. Nairn,et al.  The Dopamine/D1 Receptor Mediates the Phosphorylation and Inactivation of the Protein Tyrosine Phosphatase STEP via a PKA-Dependent Pathway , 2000, The Journal of Neuroscience.

[33]  L. Lim,et al.  Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas , 1999, Nature Cell Biology.

[34]  J. Wilsbacher,et al.  The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo * , 1999, The Journal of Biological Chemistry.

[35]  D. Barritt,et al.  Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. , 1999, Molecular biology of the cell.

[36]  W. Stallcup,et al.  High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan* , 1999, The Journal of Biological Chemistry.

[37]  T. Mustelin,et al.  Inhibition of T Cell Signaling by Mitogen-activated Protein Kinase-targeted Hematopoietic Tyrosine Phosphatase (HePTP)* , 1999, The Journal of Biological Chemistry.

[38]  T Ochiya,et al.  PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. , 1999, Journal of cell science.

[39]  A. Porter,et al.  Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis , 1998, Oncogene.

[40]  S. Howell,et al.  Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. , 1998, Investigative ophthalmology & visual science.

[41]  A. Sharrocks,et al.  The Elk-1 ETS-Domain Transcription Factor Contains a Mitogen-Activated Protein Kinase Targeting Motif , 1998, Molecular and Cellular Biology.

[42]  A. Nishiyama,et al.  A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. , 1997, Experimental cell research.

[43]  F. Ruggiero,et al.  The Membrane-spanning Proteoglycan NG2 Binds to Collagens V and VI through the Central Nonglobular Domain of Its Core Protein* , 1997, The Journal of Biological Chemistry.

[44]  R. Timpl,et al.  Binding of the NG2 Proteoglycan to Type VI Collagen and Other Extracellular Matrix Molecules* , 1996, The Journal of Biological Chemistry.

[45]  P. Itin,et al.  Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Cabañas,et al.  Activated Conformations of Very Late Activation Integrins Detected by a Group of Antibodies (HUTS) Specific for a Novel Regulatory Region(355425) of the Common 1 Chain (*) , 1996, The Journal of Biological Chemistry.

[47]  C. Heldin,et al.  Interaction between NG2 proteoglycan and PDGF α‐receptor on O2A progenitor cells is required for optimal response to PDGF , 1996, Journal of neuroscience research.

[48]  J. Iida,et al.  Spreading and Focal Contact Formation of Human Melanoma Cells in Response to the Stimulation of Both Melanoma-associated Proteoglycan (NG2) and α4β1 Integrin , 1995 .

[49]  D. Schuppan,et al.  Characterization of integrin receptors in normal and neoplastic human brain. , 1993, The American journal of pathology.

[50]  J. Prince,et al.  The primary structure of NG2, a novel membrane-spanning proteoglycan , 1991, The Journal of cell biology.

[51]  W. Vetter,et al.  Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. , 1990, The Journal of biological chemistry.

[52]  R. Ginnan,et al.  PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. , 2005, American journal of physiology. Cell physiology.

[53]  W. Stallcup,et al.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan , 2004, Angiogenesis.

[54]  K. Vuori,et al.  Engagement of the NG2 proteoglycan triggers cell spreading via rac and p130cas. , 2003, Cellular signalling.

[55]  J. Darbon,et al.  1 MAP kinase-dependent degradation of p 27 Kip 1 by calpains in choroidal melanoma cells : requirement of p 27 Kip 1 nuclear export , 2003 .

[56]  R. Garrone,et al.  NG2 proteoglycan mediates β1 integrin‐independent cell adhesion and spreading on collagen VI , 2002, Journal of cellular biochemistry.

[57]  T. Hunter,et al.  Detection and quantification of phosphotyrosine in proteins. , 1983, Methods in enzymology.